High-Dose Drug Combo Excels in Osteoporosis, but Cost a Barrier
The combination of high-dose teriparatide with denosumab could represent an ideal intervention for postmenopausal women with osteoporosis at very high risk of fracture; cost is a concern, however. Medscape Medical News …read more